Search alternatives:
significantly predicted » significantly reduced (Expand Search), significantly reduce (Expand Search), significant predictor (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
predicted decrease » predicted secreted (Expand Search), reported decrease (Expand Search)
Showing 1,341 - 1,360 results of 21,342 for search '(( significantly predicted decrease ) OR ( significant decrease decrease ))', query time: 0.49s Refine Results
  1. 1341
    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (<i>TF, Serotransferrin; F2, Prothrombin; CFI, Complement factor I; HPX, Hemopexin; C4A/C4B, Complement C4b; GC, Vitamin D-binding protein; SERPINA7, Thyroxine-binding globulin; CFB, Complement factor B; APOH, Beta-2-glycoprotein 1; NTM, Neurotrimin</i>).

    Correlation between protein abundances and R<sub>5-20</sub> z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1342
    General characteristics and clinical data of the subjects included in the study.

    General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1343
    Distribution of average relative amounts of lipid classes.

    Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1344
    Flow chart on the inclusion and drop out of patients.

    Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1345
    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls.

    Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1346
    Symptoms reported by COVID-19 cases at baseline and at follow-up.

    Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1347
    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means.

    Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

    Published 2025
    Save to List
    Saved in:
  8. 1348
    Effects of BM-MSCs on ROS generation in DCS rats.

    Effects of BM-MSCs on ROS generation in DCS rats. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1349
    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation.

    Pretreatment of BM-MSCs attenuates DCS induced lung inflammation. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1350
    Isotype control overlays.

    Isotype control overlays. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1351
    The mean and standard deviation of parameters.

    The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 1352
    Original uncropped blot.

    Original uncropped blot. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1353
    Characterization of BM-MSC.

    Characterization of BM-MSC. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1354
    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS.

    Pretreatment of BM-MSCs improves the survival rate and incidence of DCS. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1355
    Utilization of anticoagulants at eight hospitals from 2019 to 2023.

    Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1356
    The ANCOVA and Post_hoc results.

    The ANCOVA and Post_hoc results. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1357
    The demographical and clinical characteristics of subjects at baseline.

    The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1358
    Identification of BM-MSCs.

    Identification of BM-MSCs. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1359
    CONSORT flowchart.

    CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1360
    Effect of BM-MSCs in improving DCS induced lung injury.

    Effect of BM-MSCs in improving DCS induced lung injury. by Chen Lu (135200)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: